Carbamazepine Extended-Release Articles

New Rxing info for carbamazepine agreed

17 December 2007

Shire's net income improves 75% in 1st qtr

8 May 2006

Shire and Impax settle Adderall dispute

30 January 2006

Nostrum "confident" on Shire litigation

1 August 2005

Product launch costs batter Shire Pharma's 1st qtr

9 May 2005

Shire launches Equetro in USA

22 April 2005

Shire Pharma sees 3rd-qtr net income rise 19%, but fails to inspire investors

15 November 2004

Studies reveal risk of birth defects from AEDs

13 September 2004

Shire raises forecasts on good 2nd-qtr

9 August 2004

Strong performace for Shire in 2003

22 March 2004

Shire's profits up on switching strategy

3 March 2003

Shire

12 August 2002

Revenues in 1st-qtr rise 30% at Shire

6 May 2002

Shire Pharma's share price collapses due to fears of generic Adderall

11 March 2002

Shire earnings jump 54% for third quarter

7 November 2001

Shire posts major leap in pretax profits, as BioChem integration progresses

24 July 2001

Shire Pharmaceuticals pretax profits jump 50% as BioChem merger is delayed

27 April 2001

Shire benefits from strong US growth

13 May 1999

Shire profits grow despite Arenol bomb

16 March 1999

Shire Relatively Happy With 3rd Qtr

23 November 1998

Explosion At Arenol To Hit Shire Profits In 4th Qtr

18 August 1998

Shire Launches Carbatrol

30 April 1998

Elan's Zonisamide Nears US Approval

25 March 1998

Carbatrol Agreement Redrawn

29 December 1998

Net Income And EPS Soar At Ireland's Elan Corp

22 October 1997

Shire And Novo Nordisk: Epilepsy Drugs Cleared

16 October 1997

Shire To Merge With Richwood In $186m Takeover

6 August 1997

Epilepsy Market Sees Strong Growth

29 July 1997

Transitional First Quarter For Elan Corp

24 April 1997

Shire Receives Approvable Letter For Carbatrol; Lambda To Enter Ph II

26 March 1997

Showing 1-30 of 30 articles

Go to beginningPrevious
  • 1
NextGo to end